Wheeler v. GlaxoSmithKline LLC
Consolidated
Lead case: 1:15-md-02657
Lead case: 1:15-md-02657
Massachusetts District Court | |
Judge: | F Dennis Saylor, IV |
Case #: | 1:21-cv-10737 |
Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
Cause | 28:1332 Diversity-Personal Injury |
Case Filed: | May 04, 2021 |
Terminated: | Jun 03, 2021 |
Last checked: Sunday Oct 31, 2021 5:42 AM EDT |
Defendant
GlaxoSmithKline LLC
|
Represented By
|
Plaintiff
Sharon V. Wheeler
|
Represented By
|
Docket last updated: 03/31/2025 11:59 PM EDT |
Thursday, July 08, 2021 | ||
12 | 12
![]() Chief Judge F. Dennis Saylor, IV: ORDER entered: AMENDED JUDGMENT Associated Cases: 1:15-md-02657-FDS et al. (Vieira, Leonardo) |
|
Att: 1
![]() |
||
Wednesday, June 02, 2021 | ||
11 | 11
![]() Chief Judge F. Dennis Saylor, IV: ORDER entered. JUDGMENT. Associated Cases: 1:15-md-02657-FDS et al. (Vieira, Leonardo) |
|
Att: 1
![]() |
||
Tuesday, June 01, 2021 | ||
10 | 10
notice
Notice re: MDL Case Closed
Tue 06/01 3:43 PM
NOTICE OF MDL CASE CLOSED, Direct file in the District of Massachusetts; In Re: Zofran (Ondansetron)Products Liability Litigation. Associated Cases: 1:15-md-02657-FDS et al. (Vieira, Leonardo) |
|
9 | 9
![]() Chief Judge F. Dennis Saylor, IV: ORDER entered. MEMORANDUM AND ORDER: For the foregoing reasons, defendant's renewed motion for summary judgment based on federal preemption is GRANTED. This memorandum and order shall apply to all cases presently pending in this multi-district litigation proceeding. So Ordered. Associated Cases: 1:15-md-02657-FDS et al.(Vieira, Leonardo) |
|
Wednesday, May 12, 2021 | ||
8 | 8
notice
Notice - Other
Wed 05/12 5:08 PM
NOTICE: Status Conference set for 6/10/21 at 1:00 PM in Remote Proceeding: Boston before Chief Judge F. Dennis Saylor IV. Counsel of record: To gain access to the hearing please register at the following address:[LINK:https://https://forms.mad.uscourts.gov/courtlist.html] . (Counsel shall select "Public" as 'Sign-up Type'. Counsel shall enter Display Name and telephone number, for video access. This hearing will be conducted by video conference. Counsel of record will receive a video conference invite at the email registered in CM/ECF. If you have technical or compatibility issues with the technology, please notify the session's courtroom deputy as soon as possible. Access to the hearing will be made available to the media and public. In order to gain access to the hearing, you must sign up at the following address:[LINK:https://https://forms.mad.uscourts.gov/courtlist.html] .For questions regarding access to hearings, you may refer to the Court's general orders and public notices available on www.mad.uscourts.gov or contact media@mad.uscourts.gov. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violations of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, or denial of entry to future hearings, and such other sanctions, including for contempt of court, as may be deemed appropriate or necessary by the court. Associated Cases: 1:15-md-02657-FDS et al. (McKillop, Matthew) |
|
7 | 7
minutes
Status Conference
Wed 05/12 4:54 PM
Electronic Clerk's Notes for proceedings held before Chief Judge F. Dennis Saylor, IV: Status Conference held by video conference on 5/12/2021. 1) The Court heard updates on the current total of federal and state filings. 2) A colloquy was held on what supplemental disclosures and authorizations stemming from the Plaintiff Fact Sheet individual plaintiffs need to provide to GSK at this time. The Court placed a stay on any plaintiffs' duty to supplement their disclosures to GSK until the July status conference, with the exception of those plaintiffs that are subject to the specific orders lining the cases up for trial. 3) The Court heard updates on 2144 GSK's Notice of the FDA's Approval of Zofran's Updated Labeling. 4) A colloquy was held on 2146 GSK's Supplemental Expert Reports and Notice of Supplemental Authority Related to the Dormuth Study and 2147 Plaintiffs' Response. 5) A hearing was held on 203 GSK's Motion for Relief from Order and to Compel Authorizations to Collect Educational Records in Rodriguez v. GSK , 15-cv-13762. The Court denied the motion without prejudice. The Court required plaintiff to indicate when and from whom the educational records for the minor plaintiff were collected and required plaintiff to obtain a certification from the sources of the records that they are complete and accurate. 6) The Court heard argument on 104 GSK's Motion for Order to Show Cause and 110 Plaintiff's Counsel Motion to Withdraw as Attorney in Graves v. GSK , 17-cv-11562, and on 149 GSKs Motion for Order to Show Cause in Rosser v. GSK , 15-cv-14076. The Court took the matters under advisement. 7) The Court heard updates on responses to the Court's March 24, 2021 Order to Show Cause in Birt v. GSK , 15-cv-13740. 8) The Court instructed the parties to file papers on any issues related to the pretrial order in Rodriguez v. GSK , 15-cv-13762, that the parties cannot resolve themselves. 9) The Court set a status conference for Thursday, June 10, 2021 at 1:00 p.m. The conference shall be conducted by video conference. The clerk shall post video conference information on the docket via a separate entry. (Court Reporter: Valerie OHara at vaohara@gmail.com.) (Attorneys present: Various) Associated Cases: 1:15-md-02657-FDS et al. (McKillop, Matthew) |
|
Monday, May 10, 2021 | ||
6 | 6
![]() WAIVER OF SERVICE Returned Executed by Sharon V. Wheeler. GlaxoSmithKline LLC waiver sent on 5/4/2021, answer due 7/6/2021. (Zonies, Joseph) |
|
Friday, May 07, 2021 | ||
5 | 5
![]() NOTICE of Appearance by Jennifer M. Stevenson on behalf of GlaxoSmithKline LLC (Stevenson, Jennifer) |
|
Wednesday, May 05, 2021 | ||
4 | 4
![]() Summons Issued as to GlaxoSmithKline LLC. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (Baker, Casey) |
|
3 | 3
notice
Notice re: MDL Case Opened
Wed 05/05 6:21 AM
NOTICE OF MDL CASE OPENED, Direct file in the District of Massachusetts; Wheeler v. GlaxoSmithKline LLC. In Re: Zofran (Ondansetron) Products Liability Litigation, MDL 2657. (Finn, Mary) |
|
2 | 2
notice
Notice of Case Assignment
Wed 05/05 6:20 AM
ELECTRONIC NOTICE of Case Assignment. Chief Judge F. Dennis Saylor, IV assigned to case. (Finn, Mary) |
|
Tuesday, May 04, 2021 | ||
1 | 1
![]() COMPLAINT and Jury Demand against GlaxoSmithKline LLC Filing fee: $ 402, receipt number 0101-8758536 (Fee Status: Filing Fee paid), filed by Sharon V. Wheeler.(Zonies, Joseph) |
|
Att: 1
![]() |
||
Att: 2
![]() |